CURE

FDA Approves Imdelltra for Extensive-Stage Small Cell Lung Cancer

The Food and Drug Administration (FDA) granted traditional approval to Imdelltra (tarlatamab-dlle) for adult patients with ...
Healthline

Why Is Small Cell Lung Cancer So Difficult to Treat?

Small cell lung cancer (SCLC) is rarer than non-small cell lung cancer (NSCLC) but tends to be more difficult to treat. SCLC can be more resistant and aggressive than other cancers, which can increase ...
Everyday Health

What Is Small Cell Lung Cancer (SCLC)?

Small cell lung cancer (SCLC) is a fast-growing cancer that forms in the lung. It's one of two types of lung cancer. The other type is non-small cell lung cancer (NSCLC). SCLC is less common than ...
SurvivorNet on MSN

A Chicago Grandmother’s Seven-Year Journey with Small-Cell Lung Cancer: A Fight for Time, Hope, and Progress

Maida Mangiameli, 75, has defied the odds by surviving over seven years with small-cell lung cancer—a disease with a ...

First Patient Dosed in SYNERGY-101, a Global, Randomized Phase 2 Clinical Trial of STK-012 in First-Line, PD-L1 Negative Nonsquamous Non-Small Cell Lung Cancer

Synthekine Inc., an engineered cytokine therapeutics company, today announced that the company has dosed the first patient in the SYNERGY-101 study. SYNERGY-101 is a global, randomized Phase 2 ...

Ariceum Therapeutics Doses First Patient in SANTANA-225 Phase 1/2 Clinical Trial of 225Ac-SSO110 in Patients with Extensive-Stage Small Cell Lung Cancer or Merkel Cell Carcinoma

Ac-SSO110 has received U.S. FDA Orphan Drug DesignationInitial safety data from SANTANA-225 in ES-SCLC and MCC expected in 2026Potential to ...
SurvivorNet on MSN

Defying the Odds With Small Cell Lung Cancer: Montessa Lee’s 19-Year Journey Is a Beacon of Hope

Diagnosed with small-cell lung cancer at 28, Montessa Lee has defied the odds for nearly 20 years, surviving a disease with a ...